Paul Thevenot - Search Results

Year	Number of Results
2008	8
2010	5
2011	3
2012	1
2013	4
2014	4
2015	1
2016	1
2017	2
2018	2
2019	3
2020	2
2021	3
2022	5
2023	3
2024	2

1

Imaging Delay Following Liver-Directed Therapy Increases Progression Risk in Early- to Intermediate-Stage Hepatocellular Carcinoma.

Stanneart J, Nunez KG, Sandow T, Gimenez J, Fort D, Hibino M, Cohen AJ, Thevenot PT. Stanneart J, et al. Among authors: thevenot pt. Cancers (Basel). 2024 Jan 2;16(1):212. doi: 10.3390/cancers16010212. Cancers (Basel). 2024. PMID: 38201639 Free PMC article.

2

Lineage-specific regulation of PD-1 expression in early-stage hepatocellular carcinoma following 90yttrium transarterial radioembolization - Implications in treatment outcomes.

Núñez KG, Sandow T, Gimenez J, Hibino M, Fort D, Cohen AJ, Thevenot PT. Núñez KG, et al. Among authors: thevenot pt. Eur J Cancer. 2024 Jan;196:113442. doi: 10.1016/j.ejca.2023.113442. Epub 2023 Nov 17. Eur J Cancer. 2024. PMID: 37988841 Free article.

3

A Single-Step Immunocapture Assay to Quantify HCC Exosomes Using the Highly Sensitive Fluorescence Nanoparticle-Tracking Analysis.

Koksal AR, Ekmen N, Aydin Y, Nunez K, Sandow T, Delk M, Moehlen M, Thevenot P, Cohen A, Dash S. Koksal AR, et al. Among authors: thevenot p. J Hepatocell Carcinoma. 2023 Nov 2;10:1935-1954. doi: 10.2147/JHC.S423043. eCollection 2023. J Hepatocell Carcinoma. 2023. PMID: 37936599 Free PMC article.

4

The number of hepatocellular carcinoma foci as predictor of poor response to tumor-directed therapies in patients awaiting liver transplantation: a prospective cohort study.

Aydin Y, Koksal AR, Thevenot P, Nunez K, Elgamal M, Koksal UI, Sandow T, Moehlen M, Regenstein F, Tahan V, Cohen A. Aydin Y, et al. Among authors: thevenot p. Eur J Gastroenterol Hepatol. 2023 Oct 1;35(10):1224-1229. doi: 10.1097/MEG.0000000000002631. Epub 2023 Aug 14. Eur J Gastroenterol Hepatol. 2023. PMID: 37577793

5

Impaired Autophagy Response in Hepatocellular Carcinomas Enriches Glypican-3 in Exosomes, Not in the Microvesicles.

Koksal AR, Thevenot P, Aydin Y, Nunez K, Sandow T, Widmer K, Nayak L, Scott J, Delk M, Moehlen MW, Cohen AJ, Dash S. Koksal AR, et al. Among authors: thevenot p. J Hepatocell Carcinoma. 2022 Sep 7;9:959-972. doi: 10.2147/JHC.S376210. eCollection 2022. J Hepatocell Carcinoma. 2022. PMID: 36105695 Free PMC article.

6

SLAMF1 is expressed and secreted by hepatocytes and the liver in nonalcoholic fatty liver disease.

Gomez-Torres O, Amatya S, Kamberov L, Dhaibar HA, Khanna P, Rom O, Yurdagul A Jr, Orr AW, Nunez K, Thevenot P, Cohen A, Samant H, Alexander JS, Burgos-Ramos E, Chapa-Rodriguez A, Cruz-Topete D. Gomez-Torres O, et al. Among authors: thevenot p. Am J Physiol Gastrointest Liver Physiol. 2022 Sep 1;323(3):G177-G187. doi: 10.1152/ajpgi.00289.2021. Epub 2022 Jul 19. Am J Physiol Gastrointest Liver Physiol. 2022. PMID: 35853010 Free PMC article.

7

Distinct Gene Expression Profiles in Viable Hepatocellular Carcinoma Treated With Liver-Directed Therapy.

Núñez KG, Sandow T, Lakey MA, Fort D, Cohen AJ, Thevenot PT. Núñez KG, et al. Among authors: thevenot pt. Front Oncol. 2022 Jun 17;12:809860. doi: 10.3389/fonc.2022.809860. eCollection 2022. Front Oncol. 2022. PMID: 35785174 Free PMC article.

8

Hypoalbuminemia Is a Hepatocellular Carcinoma Independent Risk Factor for Tumor Progression in Low-Risk Bridge to Transplant Candidates.

Núñez KG, Sandow T, Patel J, Hibino M, Fort D, Cohen AJ, Thevenot P. Núñez KG, et al. Among authors: thevenot p. Cancers (Basel). 2022 Mar 25;14(7):1684. doi: 10.3390/cancers14071684. Cancers (Basel). 2022. PMID: 35406456 Free PMC article.

9

Experimental Validation of Novel Glypican 3 Exosomes for the Detection of Hepatocellular Carcinoma in Liver Cirrhosis.

Aydin Y, Koksal AR, Thevenot P, Chava S, Heidari Z, Lin D, Sandow T, Moroz K, Parsi MA, Scott J, Cohen A, Dash S. Aydin Y, et al. Among authors: thevenot p. J Hepatocell Carcinoma. 2021 Dec 8;8:1579-1596. doi: 10.2147/JHC.S327339. eCollection 2021. J Hepatocell Carcinoma. 2021. PMID: 34917553 Free PMC article.

10

PD-1 expression in hepatocellular carcinoma predicts liver-directed therapy response and bridge-to-transplant survival.

Núñez KG, Sandow T, Fort D, Hibino M, Wright P, Cohen AJ, Thevenot PT. Núñez KG, et al. Among authors: thevenot pt. Cancer Immunol Immunother. 2022 Jun;71(6):1453-1465. doi: 10.1007/s00262-021-03087-z. Epub 2021 Oct 24. Cancer Immunol Immunother. 2022. PMID: 34689234 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

43 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year